loading...| Preferred Name |
liarozole |
| Synonyms |
R 75251 |
| ID |
http://purl.bioontology.org/ontology/MESH/C061121 |
| altLabel |
R 75251 R-085246 R-75251 R085246 Liazal R 61405 R-61405 liarozole monohydrochloride liarozole fumarate R 085246 |
| cui |
C0972132 C0753274 C0165479 C0753275 C0245820 C0139797 C0072923 |
| HM |
D007093 |
| Inverse of RB |
145858-50-0 91W7VLK7J3 K0Q29TGV9Y 29T7S2IB97 |
| isa |
http://purl.bioontology.org/ontology/MESH/D003879 http://purl.bioontology.org/ontology/MESH/D004791 |
| LT |
TRD |
| Mapped to | |
| MDA |
19891020 |
| MeSH Frequency |
85 |
| MMR |
20141102 |
| notation |
C061121 |
| PA |
D003879 D004791 D018931 D000726 |
| prefLabel |
liarozole |
| RR |
115575-11-6 (liarozole) 145858-50-0 (mono-HCl) 91W7VLK7J3 29T7S2IB97 |
| SC |
1 |
| Scope Statement |
inhibits all-trans-retinoic acid 4-hydroxylase; effective against hormone-dependent and hormone-independent tumors; R 75251 is chlorohydrate of R 61405; a potent inhibitor of retinoic acid metabolism; USAN name - liarozole fumarate |
| SRC |
Prog Clin Biol Res 1989;303:205 |
| TERMUI |
T199554 T199556 T199555 T199551 T199557 T199548 T199553 T199549 T199550 T354366 T199552 |
| TH |
FDA SRS (2015) FDA SRS (2013) USAN (19XX) NLM (1989) USAN (1994) INN (19XX) |
| tui |
T109 T121 |